NASDAQ:OTLK

Outlook Therapeutics Stock Forecast

etoro logo Buy OTLK
*Your capital is at risk
$1.61
-0.0700 (-4.17%)
At Close: Jun 25, 2026
AI Analysis AI Analysis of OTLK AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add OTLK to Watchlist?
Some Reasons Why To Add OTLK:
  • Strong return on equity of 178.1%
  • +143.9% YTD performance
  • Highly efficient cash conversion (100% FCF/OCF ratio)
PDF

High volatility in Outlook Therapeutics Inc. stock price on Thursday which ended trading at $1.61
(Updated on Jun 25, 2026)

Buy or Hold candidate since May 20, 2026 Gain 489.74%

The Outlook Therapeutics Inc. stock price fell by -4.17% on the last day (Thursday, 25th Jun 2026) from $1.68 to $1.61. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 11.70% from a day low at $1.54 to a day high of $1.72. The price has been going up and down for this period, and there has been a 80.9% gain for the last 2 weeks. Volume has increased on the last day by 513 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 9 million shares were bought and sold for approximately $14.51 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 219.19% during the next 3 months and, with a 90% probability hold a price between $2.40 and $6.04 at the end of this 3-month period.

OTLK Signals & Forecast

The Outlook Therapeutics Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $1.66. On a fall, the stock will find some support from the long-term average at approximately $0.775. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, June 22, 2026, and so far it has fallen -12.02%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Outlook Therapeutics Inc. stock

Outlook Therapeutics Inc. finds support from accumulated volume at $1.58 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.180 between high and low, or 11.70%. For the last week, the stock has had daily average volatility of 15.96%.

Our recommended stop-loss: $1.54 (-4.52%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 3 days ago.)

Trading Expectations (OTLK) For The Upcoming Trading Day Of Friday 26th

For the upcoming trading day on Friday, 26th we expect Outlook Therapeutics Inc. to open at $1.62, and during the day (based on 14 day Average True Range), to move between $1.52 and $1.70, which gives a possible trading interval of +/-$0.178 (+/-11.73%) up or down from last closing price. If Outlook Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 11.73% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.58 (1.86%) than the resistance at $1.65 (2.48%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Outlook Therapeutics Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Outlook Therapeutics Inc. stock to perform well in the short-term.

Current score: 2.970 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 26, 2026 - $1.62 ( 0.83%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

OTLK Performance

Trading levels for OTLK

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 1.80 12.02%
R2 1.73 7.75%
R1 1.69 5.11%
Price 1.61
S1 1.55 -3.44%
S2 1.51 -6.08%
S3 1.44 -10.36%

Accumulated Volume Support & Resistance Levels

Level Price
R3 1.83 13.66%
R2 1.70 5.59%
R1 1.65 2.48%
Price 1.61
S1 1.58 -1.86%
S2 1.57 -2.48%
S3 1.22 -24.22%

FAQ

What is the symbol for Outlook Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Outlook Therapeutics Inc. is OTLK and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Outlook Therapeutics Inc. Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Outlook Therapeutics Inc. stock to perform well in the short-term.

How to buy Outlook Therapeutics Inc. Stock?
Outlook Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Outlook Therapeutics Inc. Stock.

What's the current price of Outlook Therapeutics Inc. Stock?
As of the end of day on the Jun 25, 2026, the price of an Outlook Therapeutics Inc. (OTLK) share was $1.61.

What is the 52-week high and low for Outlook Therapeutics Inc. Stock?
The 52-week high for Outlook Therapeutics Inc. Stock is $3.39 and the 52-week low is $0.161.

What is the market capitalization of Outlook Therapeutics Inc. Stock?
As of the Jun 25, 2026, the market capitalization of Outlook Therapeutics Inc. is 66.236M.

When is the next earnings date for Outlook Therapeutics Inc.?
The upcoming earnings date for Outlook Therapeutics Inc. is Aug 13, 2026.
Click to get the best stock tips daily for free!
ABOUT OUTLOOK THERAPEUTICS INC.
Outlook Therapeutics
Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-related macular degeneration and other retina diseases. Outlook Therapeutics, Inc. has collaboration and lice...
GOLDEN STAR
Ticker Change Signal Date
JLL
$298.94
1.61% Jun 23
CBRE
$133.21
1.03% Jun 23
CAG
$13.43
2.72% Jun 23
TTEK
$28.04
1.43% Jun 23
NESR
$25.07
7.62% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE